Page 165 - Philips News Today

Dutch health technology company Philips will not sell new devices to treat sleep apnea in the U.S. as it works to comply with an FDA settlement.

European markets open mixed on a busy week for earnings, central bank announcements and data.

The company behind a global recall of sleep apnea machines said Monday it will stop selling the devices in the U.S., under a tentative agreement with regulators that could cost the manufacturer nearly $400 million. Device maker Philips has recalled more than 5 million pressurized breathing machines due to risks that their internal foam can break down over time, leading users to inhale tiny particles and fumes while they sleep. Philips executives disclosed the tentative agreement during a quart...

U.S. stock futures were mixed this morning, with the Dow futures falling around 50 points on Monday.

PLEASANTON, Calif., Jan. 29, 2024 -- ProSomnus, Inc. , the leading non-CPAP Obstructive Sleep Apnea therapy™, announced that the company is well-positioned to support patients with OSA and...

Ticker

OPENING CALL Stock futures wavered on Monday ahead of a busy week filled with earnings, a policy meeting of the Federal Reserve, and the monthly jobs report. Around 100 S&P 500 companies are... -January 29, 2024 at 06:12 am EST - MarketScreener

The breathing machine manufacturer has faced relentless criticism over its handling of the 2021 recall of millions of devices. Philips must meet the requirements outlined in an agreement with the Justice Department before it can resume sales.

Explore affordable and thoughtful gift ideas for women this Valentines Day, all under 1000. Make her feel cherished on this special day with unique and affordable presents.

Shares within points of all-time high; Megaport shares soar after booking higher revenue; City Chic confirms interest from offshore suitors. Follow updates here.